{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:40:08Z","timestamp":1756327208663,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,10,26]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>The clinical spectrum of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) with renal involvement includes forms with a slowly progressive course. These forms are poorly recognised and, therefore, often associated with misdiagnosis and delayed treatment. We present here a case of slowly progressive AAV with renal involvement. A patient in her 50s with long-standing hypertension was evaluated for chronic renal impairment. Laboratory diagnostics revealed mild glomerular disease with relevant proteinuria and glomerular microhaematuria. Furthermore, significantly elevated ANCA of the antimyeloperoxidase (MPO-ANCA) type was detected. Renal biopsy provided evidence of arteriolosclerosis with an increased number of obliterated glomeruli but no evidence of active glomerulonephritis. The initiation of immunosuppressive therapy led to an improvement in both the clinical and the laboratory courses.<\/jats:p>\n               <jats:p>Our case emphasises the importance of ANCA testing, particularly in cases of unclear glomerulopathy with an atypical presentation of ANCA-associated glomerulonephritis. It also illustrates the diagnostic challenges often encountered with slowly progressive AAV.<\/jats:p>","DOI":"10.1136\/bcr-2024-260740","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T07:10:33Z","timestamp":1731568233000},"page":"e260740","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["ANCA-associated vasculitis with slowly progressive renal dysfunction: a little-known but treatable disease"],"prefix":"10.1136","volume":"17","author":[{"given":"Jan","family":"Albers","sequence":"first","affiliation":[{"name":"Nephrology and Dialysis, Kantonsspital Baden AG, Baden, Aargau, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Seeger","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis, Kantonsspital Baden AG, Baden, Aargau, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[{"name":"Addenbrooke's Hospital, Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1833-3566","authenticated-orcid":false,"given":"Andrea Elisabeth","family":"Fisler","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis, Kantonsspital Baden AG, Baden, Aargau, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"2025082713172540000_17.11.e260740.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.04.031"},{"key":"2025082713172540000_17.11.e260740.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"2025082713172540000_17.11.e260740.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.006"},{"key":"2025082713172540000_17.11.e260740.4","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa139"},{"key":"2025082713172540000_17.11.e260740.5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ckj\/sfaa181","article-title":"Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitis","volume":"14","author":"Avello","year":"2021","journal-title":"Clin Kidney J"},{"key":"2025082713172540000_17.11.e260740.6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13730-021-00663-1","article-title":"A case of smoldering antineutrophil cytoplasmic antibody-associated vasculitis development during the course of primary Sj\u00f6gren\u2019s syndrome","volume":"11","author":"Iwafuchi","year":"2022","journal-title":"CEN Case Rep"},{"key":"2025082713172540000_17.11.e260740.7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2169\/internalmedicine.41.458","article-title":"MPO-ANCA-positive slowly progressive glomerulonephritis with focal tuft necrosis and crescents","volume":"41","author":"Aoyama","year":"2002","journal-title":"Intern Med"},{"key":"2025082713172540000_17.11.e260740.8","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2169\/internalmedicine.9844-17","article-title":"Emergence of Smoldering ANCA-associated Glomerulonephritis during the Clinical Course of Mixed Connective Tissue Disease and Sj\u00f6gren\u2019s Syndrome","volume":"57","author":"Morimoto","year":"2018","journal-title":"Intern Med"},{"key":"2025082713172540000_17.11.e260740.9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfk037"},{"key":"2025082713172540000_17.11.e260740.10","doi-asserted-by":"crossref","first-page":"103100","DOI":"10.1016\/j.autrev.2022.103100","article-title":"Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis","volume":"21","author":"Walker","year":"2022","journal-title":"Autoimmun Rev"},{"key":"2025082713172540000_17.11.e260740.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.140"},{"key":"2025082713172540000_17.11.e260740.12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000521862","article-title":"Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA","volume":"12","author":"Garo","year":"2022","journal-title":"Case Rep Nephrol Dial"},{"key":"2025082713172540000_17.11.e260740.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209133"},{"key":"2025082713172540000_17.11.e260740.14","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764"},{"key":"2025082713172540000_17.11.e260740.15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q","article-title":"Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions","volume":"13","author":"Stone","year":"2000","journal-title":"Arthritis & Rheum"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2024-260740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T20:17:31Z","timestamp":1756325851000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2024-260740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,14]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bcr-2024-260740"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2024-260740","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}